BridgeBio Pharma (BBIO) EBT Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 3.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.81% |
| Dec 31, 2025 | 26.85% |
| Sep 30, 2025 | -13.53% |
| Jun 30, 2025 | -140.47% |
| Mar 31, 2025 | -514.64% |
| Dec 31, 2024 | -38.59% |
| Sep 30, 2024 | 5.71% |
| Jun 30, 2024 | 53.42% |
| Mar 31, 2024 | 86.59% |
| Dec 31, 2023 | -32.37% |
| Sep 30, 2023 | -18.89% |
| Jun 30, 2023 | -62.68% |
| Mar 31, 2023 | 26.64% |
| Dec 31, 2022 | 19.62% |
| Sep 30, 2022 | 8.61% |
| Jun 30, 2022 | 4.63% |
| Mar 31, 2022 | -9.56% |
| Dec 31, 2021 | -30.84% |
| Sep 30, 2021 | -23.17% |
| Jun 30, 2021 | 22.22% |
| Mar 31, 2021 | -69.14% |
| Dec 31, 2020 | -74.10% |
| Sep 30, 2020 | -141.47% |
| Jun 30, 2020 | -93.09% |
| Mar 31, 2020 | -65.13% |
| Dec 31, 2019 | -21.41% |
| Sep 30, 2019 | -28.10% |
| Jun 30, 2019 | -98.93% |